The global Blockchain in Healthcare Market size was valued at USD 3.80 billion in 2025 and is estimated at USD 5.05 billion in 2026, forecast to reach USD 70.00 billion by 2035, expanding at a 33.9% CAGR between 2026 and 2035. North America leads with approximately 36% share, while software dominates all other offerings with approximately 68% share.
We observed that growth is broad-based across every segmentation axis, with clinical data exchange platforms and consortium-architecture deployments driving the dominant structural shifts through 2035.
|
Key Takeaways |
|
By Offering: Software held the largest share of approximately 68% (USD 2.58 Billion) in 2025; Software is also the fastest-growing offering at 34.7% CAGR from 2026–2035. |
|
By Application: Clinical Data Exchange held the largest share of approximately 21% (USD 0.80 Billion) in 2025; Medical Device Tracking is the fastest-growing sub-segment at 36.8% CAGR from 2026–2035. |
|
By Deployment: Public Cloud held the largest share of approximately 31% (USD 1.18 Billion) in 2025; Hybrid Cloud is the fastest-growing sub-segment at 36.2% CAGR from 2026–2035. |
|
By Blockchain Architecture: Private architecture held the largest share of approximately 34% (USD 1.29 Billion) in 2025; Hybrid architecture is the fastest-growing sub-segment at 37.4% CAGR from 2026–2035. |
|
By Revenue Model: Subscription revenue held the largest share of approximately 42% (USD 1.60 Billion) in 2025; Consumption-Based revenue is the fastest-growing sub-segment at 37.3% CAGR from 2026–2035. |
|
By Organization Size: Large Enterprise held the largest share of approximately 52% (USD 1.98 Billion) in 2025; Small Enterprise is the fastest-growing sub-segment at 36.8% CAGR from 2026–2035. |
|
By End User: Healthcare Providers held the largest share of approximately 34% (USD 1.29 Billion) in 2025; Patients is the fastest-growing sub-segment at 36.4% CAGR from 2026–2035. |
|
Dominant Region: North America dominated with approximately 36% revenue share (USD 1.37 Billion) in 2025. |
|
Fastest-Growing Region: Asia-Pacific is expected to register the highest CAGR of 36.8% during 2026–2035. |
|
Dominant Country: U.S. led with approximately USD 1.12 Billion in 2025. |
|
Fastest-Growing Country: India is the fastest-growing country at approximately 39.7% CAGR from 2026–2035. |
Market Opportunity: The blockchain in healthcare market is expected to create an absolute dollar opportunity of USD 64.95 billion between 2026 and 2035, presenting significant investment potential across the clinical data exchange, drug supply chain, and healthcare payments value chain.
According to Next Move Strategy Consulting analysis, healthcare providers and payers are increasingly consolidating blockchain deployments onto consortium-governed networks with pre-vetted interoperability partners, a shift that favors platform vendors with proven regulatory-compliance track records over single-use pilot developers as enterprise procurement scrutiny intensifies through 2035.
The blockchain in healthcare market encompasses distributed ledger software, platforms, and services that enable secure, tamper-evident data exchange, identity verification, and transaction settlement across hospitals, payers, life sciences companies, and pharmacies.
Our assessment indicates that the scope spans blockchain infrastructure, smart contract platforms, and identity and interoperability layers deployed across public, private, consortium, and hybrid network architectures to support clinical data exchange, drug supply chain traceability, claims adjudication, and patient engagement use cases. The category has evolved from isolated pilot projects into production-grade consortium networks, driven by rising cyber-breach costs, interoperability mandates, and payer demand for fraud-resistant claims processing.
Regulatory frameworks such as the U.S. Health Insurance Portability and Accountability Act and the CMS Interoperability and Prior Authorization Final Rule shape data-exchange and consent-management requirements, while the European Health Data Space regulation increasingly influences consortium-architecture adoption across member states. We observed that technology adoption is shifting toward permissioned and consortium networks that align with HIPAA, GDPR, and TEFCA requirements. Next Move Strategy Consulting's analysis indicates that this structural shift, combined with payer fraud-reduction mandates, is redefining sourcing criteria across the blockchain in healthcare market.
Market Opportunity: The blockchain in healthcare market is expected to create an absolute dollar opportunity of USD 64.95 billion between 2026 and 2035, presenting significant investment potential across the clinical data exchange, drug supply chain, and healthcare payments value chain.
According to Next Move Strategy Consulting analysis, healthcare providers and payers are increasingly consolidating blockchain deployments onto consortium-governed networks with pre-vetted interoperability partners, a shift that favors platform vendors with proven regulatory-compliance track records over single-use pilot developers as enterprise procurement scrutiny intensifies through 2035.
|
Parameters |
Details |
|
Market Size in 2025 |
USD 3.80 Billion |
|
Market Size in 2026 |
USD 5.05 Billion |
|
Revenue Forecast in 2035 |
USD 70.00 Billion |
|
Growth Rate |
CAGR of 33.9% from 2026 to 2035 |
|
Analysis Period |
2025–2035 |
|
Base Year Considered |
2025 |
|
Forecast Period |
2026–2035 |
|
Market Size Estimation |
Revenue (USD Billion) |
|
Companies Profiled |
20 |
|
Countries Covered |
33 |
|
Market Share |
Available for Top 10 Companies |
Based on research conducted by Next Move Strategy Consulting, we found that four structural trends are reshaping platform architecture, procurement, and stakeholder engagement across the industry.
Consortium-governed blockchain networks are replacing single-vendor pilots to meet multi-stakeholder interoperability requirements across hospital systems and payer networks. We observed that Change Healthcare's continued rebuild of claims infrastructure following its 2024 breach has accelerated payer interest in consortium-based, tamper-evident claims networks. Health systems are adopting these architectures to satisfy TEFCA participation requirements, while payers retool adjudication pipelines to accommodate shared, permissioned ledgers across regional provider networks.
Smart contract-based adjudication is gaining traction as payers seek to automate prior authorization and reduce duplicate claims processing costs. Our findings suggest that insurers piloting smart contract settlement logic are cutting manual review cycles for routine claims. Health plans are adopting these mechanisms to satisfy CMS interoperability mandates, while third-party administrators redesign adjudication workflows to accommodate self-executing, rules-based contract logic across member reimbursement processes.
Decentralized identity frameworks are replacing siloed credentialing systems to meet cross-institution verification needs for patients and providers alike. We observed that health systems piloting self-sovereign identity wallets are reducing duplicate patient-matching errors across referral networks. Provider networks are adopting these frameworks to satisfy credential-verification requirements, while payers integrate decentralized identity checks to streamline network enrollment and reduce provider directory inaccuracies.
Drug traceability platforms built on distributed ledgers are emerging as a compliance response to counterfeit-drug scrutiny under the U.S. Drug Supply Chain Security Act. Our analysis shows that pharmaceutical distributors piloting blockchain-based serialization are improving track-and-trace visibility across multi-tier supply networks. This trend is elevating demand for interoperable traceability nodes among wholesalers, while manufacturers redesign packaging-data capture to minimize counterfeit infiltration during last-mile pharmacy distribution.
Based on our competitive assessment, we observed that supplier bargaining power, buyer bargaining power, competitive rivalry, the threat of substitutes, and the threat of new entrants collectively shape the blockchain in healthcare market. Furthermore, our market analysis indicates that technology providers, healthcare organizations, regulatory requirements, interoperability standards, cybersecurity investments, and digital health adoption influence competitive intensity, strengthen innovation, improve market differentiation, and support sustainable long-term market growth.
|
Factors |
Type |
(+/−) % Impact on CAGR |
Geographic Relevance |
Impact Timeline |
|
Rising healthcare data-breach costs and cyber incidents |
Driver |
+4.8% |
Global |
2026–2035 |
|
CMS Interoperability and Prior Authorization Final Rule |
Driver |
+4.1% |
North America |
2026–2035 |
|
European Health Data Space regulation adoption |
Driver |
+3.4% |
Europe |
2026–2035 |
|
Rising drug counterfeiting and traceability mandates |
Driver |
+3.0% |
Global |
2026–2035 |
|
Expansion of digital health infrastructure in Asia-Pacific |
Driver |
+3.6% |
Asia-Pacific |
2026–2035 |
|
Payer demand for fraud-resistant claims adjudication |
Driver |
+2.5% |
Global |
2026–2032 |
|
High integration cost with legacy hospital IT systems |
Restraint |
−2.4% |
Global |
2026–2035 |
|
Fragmented regulatory standards across jurisdictions |
Restraint |
−1.8% |
Global |
2026–2032 |
|
Limited blockchain technical talent in healthcare IT teams |
Restraint |
−1.2% |
Global |
2028–2035 |
Rising healthcare data-breach costs following large-scale incidents are the primary driver of the market. The U.S. Department of Health and Human Services Office for Civil Rights continues to track breach notifications affecting hundreds of millions of records under HIPAA reporting requirements. We observed that this exposure, reinforced by mandatory 60-day breach-reporting timelines, continues to anchor baseline investment in tamper-evident ledger infrastructure across developed and emerging healthcare systems alike.
The CMS Interoperability and Prior Authorization Final Rule and the European Health Data Space regulation are accelerating market growth toward API-based, ledger-backed data exchange. The Centers for Medicare & Medicaid Services requires API-based data sharing across Medicare Advantage, Medicaid, and CHIP programs. Our assessment indicates that this regulatory pressure, combined with payer sustainability scorecards for administrative efficiency, is compressing adoption timelines for consortium-architecture platforms across North America and Europe.
High integration costs with legacy hospital information systems restrain adoption pace across the provider segment. The U.S. Department of Health and Human Services continues to document interoperability barriers tied to legacy electronic health record architecture. We found that smaller regional hospital systems face particular exposure, as limited capital budgets reduce their ability to fund ledger-integration projects compared with larger, well-capitalized academic medical centers.
|
Segment |
2025 (USD) |
2035 (USD) |
CAGR% (2026–2035) |
|
Software |
USD 2.58 Billion |
USD 50.05 Billion |
34.7% |
|
Services |
USD 1.22 Billion |
USD 19.95 Billion |
32.2% |
|
Total |
USD 3.80 Billion |
USD 70.00 Billion |
33.9% |
Software, encompassing platform and application software layers, led the market with USD 2.58 billion in 2025, supported by rising demand for clinical data exchange and identity-management platforms. We observed that Software is also the fastest-growing offering, expanding at a 34.7% CAGR from 2026 to 2035, as healthcare organizations shift budgets from professional-services pilots toward production-grade platform licensing.
|
Segment |
2025 (USD) |
2035 (USD) |
CAGR% (2026–2035) |
|
Clinical Data Exchange |
USD 0.80 Billion |
USD 14.35 Billion |
33.6% |
|
Drug Supply Chain |
USD 0.61 Billion |
USD 10.85 Billion |
33.4% |
|
Claims and Billing |
USD 0.49 Billion |
USD 8.75 Billion |
33.3% |
|
Clinical Research |
USD 0.42 Billion |
USD 8.40 Billion |
35.1% |
|
Patient Identity |
USD 0.34 Billion |
USD 6.65 Billion |
34.9% |
|
Provider Credentialing |
USD 0.27 Billion |
USD 4.55 Billion |
33.0% |
|
Patient Engagement |
USD 0.30 Billion |
USD 5.95 Billion |
35.0% |
|
Healthcare Payments |
USD 0.27 Billion |
USD 5.25 Billion |
35.1% |
|
Medical Device Tracking |
USD 0.19 Billion |
USD 4.20 Billion |
36.8% |
|
Other Healthcare Applications |
USD 0.11 Billion |
USD 1.05 Billion |
23.2% |
|
Total |
USD 3.80 Billion |
USD 70.00 Billion |
33.9% |
Clinical Data Exchange remained the leading application within the market, valued at USD 0.80 billion in 2025 on sustained electronic health record and health information exchange consumption. Our findings suggest that Medical Device Tracking is the fastest-growing application, registering a 36.8% CAGR from 2026 to 2035, as hospitals increasingly deploy ledger-based digital twins in healthcare alongside device-authentication nodes to improve lifecycle traceability across implantable and capital medical equipment.
|
Segment |
2025 (USD) |
2035 (USD) |
CAGR% (2026–2035) |
|
Healthcare Providers |
USD 1.29 Billion |
USD 22.40 Billion |
33.0% |
|
Healthcare Payers |
USD 0.68 Billion |
USD 12.25 Billion |
33.5% |
|
Life Sciences |
USD 0.84 Billion |
USD 16.45 Billion |
34.9% |
|
Government |
USD 0.34 Billion |
USD 6.65 Billion |
34.9% |
|
Pharmacies and Distributors |
USD 0.27 Billion |
USD 5.25 Billion |
35.1% |
|
Research Organizations |
USD 0.19 Billion |
USD 3.85 Billion |
35.5% |
|
Patients |
USD 0.11 Billion |
USD 2.45 Billion |
36.4% |
|
Other Healthcare Organizations |
USD 0.08 Billion |
USD 0.70 Billion |
22.8% |
|
Total |
USD 3.80 Billion |
USD 70.00 Billion |
33.9% |
Healthcare Providers remained the leading end user within the market, reaching USD 1.29 billion in 2025 due to hospitals' and clinics' central role in clinical data exchange and patient-identity workflows. Based on research conducted by Next Move Strategy Consulting, we found that Patients represent the fastest-growing end-user category at a 36.4% CAGR from 2026 to 2035, reflecting rising direct-to-consumer personal health record and wellness-tracking adoption.
Our analysis shows that three forward-looking opportunities stand out for stakeholders positioning within the blockchain in healthcare market over the 2026–2035 forecast period.
Ledger-based provider credentialing platforms present a whitespace opportunity for health systems and payer networks seeking to cut credential-verification turnaround time. Vendors that commercialize shared credential repositories integrated with consumer identity and access management (IAM) tooling stand to capture recurring subscription revenue as networks shift toward continuous, real-time license monitoring across multi-state provider panels.
Pharmaceutical wholesalers and distributors represent an underpenetrated opportunity for interoperable traceability nodes engineered to Drug Supply Chain Security Act serialization requirements. Vendors that develop validated, cross-network track-and-trace platforms for wholesalers and hospital pharmacies can secure long-term procurement contracts, benefiting from recurring transaction-fee revenue tied to counterfeit-prevention compliance programs.
Payer-provider consortium networks seeking fraud-resistant claims adjudication create an opportunity for platform vendors offering shared, permissioned settlement infrastructure. Early movers that secure multi-payer consortium participation for smart-contract-based claims processing can differentiate with health plans pursuing administrative-cost reduction across their member reimbursement operations.
|
Region |
2025 (USD) |
2035 (USD) |
CAGR% (2026–2035) |
Key Driver |
|
North America |
USD 1.37 Billion |
USD 23.10 Billion |
32.6% |
Mature digital health infrastructure and CMS interoperability mandates |
|
Europe |
USD 1.03 Billion |
USD 16.80 Billion |
32.2% |
European Health Data Space regulation and GDPR-driven data-governance requirements |
|
Asia-Pacific |
USD 0.91 Billion |
USD 20.30 Billion |
36.8% |
Expanding digital health infrastructure and government-backed health ID programs |
|
Middle East & Africa |
USD 0.30 Billion |
USD 6.30 Billion |
35.8% |
Vision-linked healthcare digitization and hospital modernization programs |
|
Latin America |
USD 0.19 Billion |
USD 3.50 Billion |
33.5% |
Growing digital health investment and expanding health-insurance modernization |
|
Total |
USD 3.80 Billion |
USD 70.00 Billion |
33.9% |
— |
North America leads the blockchain in healthcare market with an established digital health infrastructure and mature payer ecosystem. We observed that CMS interoperability requirements sustain demand for API-based, ledger-backed data exchange, while health systems increasingly specify consortium architectures to meet TEFCA participation requirements. Technology adoption remains advanced, with payer networks driving demand for smart-contract-based claims adjudication across the region's cost-sensitive healthcare sector.
Europe's blockchain in healthcare market reflects a regulation-intensive landscape shaped by the European Health Data Space and GDPR data-governance frameworks. Our findings suggest that health systems across Germany, France, and the UK are accelerating adoption of consortium-governed data-exchange platforms to satisfy harmonized cross-border health-data requirements. Regulatory influence remains strong, with national health authorities increasingly specifying interoperable, auditable ledger platforms for cross-institution data sharing.
Asia-Pacific is expanding rapidly on the back of government-backed digital health ID programs and rising hospital IT investment. We found that China, India, and Japan are scaling national health-record digitization initiatives that increasingly incorporate ledger-based data-integrity layers. Technology adoption is accelerating as regional health systems modernize legacy infrastructure, positioning the region as the fastest-growing across the forecast period.
The Middle East & Africa blockchain in healthcare market is expanding on the back of national digital-transformation strategies and hospital modernization programs. Our assessment indicates that Gulf Cooperation Council health authorities are piloting ledger-based patient-identity and claims platforms to support universal health-coverage rollouts. Regulatory influence is growing as regional ministries of health establish digital-health governance frameworks aligned with international interoperability standards.
Latin America's blockchain in healthcare market is growing alongside expanding digital health investment and health-insurance modernization. We observed that Brazil and Argentina are piloting ledger-based claims and drug-traceability platforms to reduce administrative fraud within national health systems. Technology adoption remains early-stage relative to developed regions, though strategic outlook favors accelerating consortium-network deployment as regional insurers digitize claims infrastructure.
Based on our estimates, U.S.'s blockchain in healthcare market was valued at approximately USD 1.12 billion in 2025 and is projected to reach USD 18.48 billion by 2035, expanding at a 32.3% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and HIPAA breach-reporting requirements and CMS interoperability mandates continue to anchor demand for tamper-evident data-exchange platforms across hospital and payer networks. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
The market in Canada was valued at approximately USD 0.18 billion in 2025 and is projected to reach USD 3.23 billion by 2035, expanding at a 33.5% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and provincial health-record modernization programs are increasingly incorporating ledger-based consent-management layers across regional health authorities. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
As per our estimate, UK's blockchain in healthcare market was valued at approximately USD 0.23 billion in 2025 and is projected to reach USD 3.53 billion by 2035, expanding at a 31.5% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the National Health Service continues to pilot interoperable data-exchange platforms supporting cross-trust patient-record sharing. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
According to our analysis, Germany's blockchain in healthcare market was valued at approximately USD 0.25 billion in 2025 and is projected to reach USD 3.86 billion by 2035, expanding at a 31.4% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the electronic patient record rollout under national digital-health legislation is accelerating demand for auditable, ledger-backed consent frameworks. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
Based on our estimates, France's blockchain in healthcare market was valued at approximately USD 0.16 billion in 2025 and is projected to reach USD 2.69 billion by 2035, expanding at a 32.1% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the Mon Espace Santé national health-data platform is increasingly integrating interoperable data-exchange standards across regional hospital networks. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
The market in China was valued at approximately USD 0.27 billion in 2025 and is projected to reach USD 6.50 billion by 2035, expanding at a 37.9% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and national health-record digitization initiatives are scaling ledger-based data-integrity layers across provincial hospital systems. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
As per our estimate, India's blockchain in healthcare market was valued at approximately USD 0.15 billion in 2025 and is projected to reach USD 4.26 billion by 2035, expanding at a 39.7% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the Ayushman Bharat Digital Mission continues to expand health-ID and facility-registry infrastructure that increasingly incorporates distributed-ledger verification. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
According to our analysis, Japan's blockchain in healthcare market was valued at approximately USD 0.17 billion in 2025 and is projected to reach USD 3.25 billion by 2035, expanding at a 34.2% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and national electronic health-record standardization efforts are incorporating interoperable data-exchange layers across regional medical networks. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
Based on our estimates, South Korea's blockchain in healthcare market was valued at approximately USD 0.11 billion in 2025 and is projected to reach USD 2.44 billion by 2035, expanding at a 36.3% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and government-backed digital-health initiatives are accelerating hospital adoption of ledger-based patient-data exchange platforms. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
The market in Australia was valued at approximately USD 0.07 billion in 2025 and is projected to reach USD 1.62 billion by 2035, expanding at a 36.3% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the My Health Record national platform is increasingly exploring interoperable, ledger-backed consent-management extensions. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
As per our estimate, UAE's blockchain in healthcare market was valued at approximately USD 0.07 billion in 2025 and is projected to reach USD 1.58 billion by 2035, expanding at a 35.9% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the Ministry of Health and Prevention continues to pilot unified digital-health platforms incorporating distributed-ledger data-integrity layers. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
According to our analysis, Saudi Arabia's blockchain in healthcare market was valued at approximately USD 0.08 billion in 2025 and is projected to reach USD 1.76 billion by 2035, expanding at a 36.1% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and Vision 2030-linked healthcare digitization programs are accelerating hospital adoption of ledger-based claims and identity platforms. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
Based on our estimates, South Africa's blockchain in healthcare market was valued at approximately USD 0.03 billion in 2025 and is projected to reach USD 0.69 billion by 2035, expanding at a 37.2% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and national health-insurance digitization efforts are incorporating early-stage ledger-based claims-verification pilots across public hospital networks. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
The market in Brazil was valued at approximately USD 0.09 billion in 2025 and is projected to reach USD 1.54 billion by 2035, expanding at a 32.8% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and the national health system continues to pilot ledger-based claims platforms to reduce administrative fraud across regional insurers. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
As per our estimate, Argentina's blockchain in healthcare market was valued at approximately USD 0.03 billion in 2025 and is projected to reach USD 0.63 billion by 2035, expanding at a 35.8% CAGR from 2026 to 2035. Demand structure reflects a mix of institutional and payer-driven adoption, and expanding digital-health investment is accelerating early-stage adoption of interoperable data-exchange platforms across provincial hospital networks. Competitive intensity is rising as global platform vendors expand local partnerships, while regulatory influence and technology penetration continue to shape the country's strategic outlook through the forecast period.
Based on our market assessment, we identified that implementation costs, user adoption barriers, competitive pressure, technological limitations, interoperability gaps, and regulatory compliance challenges collectively influence the blockchain in healthcare market. Moreover, our industry evaluation highlights that high deployment expenses, complex healthcare workflows, legacy infrastructure, scalability concerns, fragmented interoperability standards, and evolving data privacy regulations delay implementation, increase operational complexity, hinder seamless integration, and restrain widespread market adoption.
Next Move Strategy Consulting's analysis indicates that the competitive landscape is moderately fragmented, spanning diversified technology conglomerates, specialized blockchain-health platform vendors, and healthcare payer-affiliated ventures.
|
Dimension |
Details |
|
Market Structure |
Moderately fragmented, with diversified technology conglomerates competing alongside specialized blockchain-health platform vendors and payer-affiliated ventures. |
|
Innovation Focus |
Consortium-network interoperability, smart-contract claims adjudication, and decentralized identity verification. |
|
M&A Activity |
Selective acquisitions of specialized health-data interoperability and identity-verification startups by diversified technology vendors. |
Companies compete primarily on interoperability breadth, regulatory-compliance depth, and the ability to onboard multi-stakeholder consortium networks at scale. Our analysis shows that diversified technology vendors leverage existing enterprise cloud relationships with hospital systems to cross-sell ledger-based data-exchange modules, while specialized blockchain-health vendors differentiate through purpose-built healthcare compliance features and faster consortium-onboarding timelines.
Two archetypes dominate the industry: diversified enterprise technology vendors offering blockchain as one module within broader healthcare cloud suites, and specialized blockchain-health platform vendors built exclusively around distributed-ledger data exchange. We found that the diversified archetype benefits from existing payer and hospital IT relationships, while the specialized archetype wins on healthcare-specific compliance depth and faster deployment for niche use cases such as drug traceability.
Companies are prioritizing consortium-network expansion, smart-contract claims-adjudication modules, and decentralized identity integration as core differentiation strategies. We observed that vendors investing in pre-built TEFCA and CMS interoperability connectors are reducing hospital onboarding timelines, positioning themselves favorably against generalist cloud providers lacking healthcare-specific regulatory tooling.
Diversified technology vendors continue to pursue selective acquisitions of specialized health-data interoperability and identity-verification startups to accelerate healthcare-specific product depth. Our assessment indicates that geographic expansion is concentrated in Asia-Pacific, where vendors are establishing local partnerships with national digital-health authorities to support government-backed health-ID and hospital-digitization programs.
Next Move Strategy Consulting's analysis indicates that the following 20 companies represent the leading validated participants shaping the blockchain in healthcare market.
Microsoft Corporation
SAP SE
UnitedHealth Group Incorporated
Guardtime AS
Consensys Software Inc.
Chronicled, Inc.
BurstIQ, Inc.
Solve.Care Foundation
Avaneer Health, Inc.
Hashed Health, LLC
Patientory, Inc.
Medicalchain SA
Embleema SAS
StaTwig Technologies Pvt. Ltd.
HealthVerity, Inc.
Briya Ltd.
iSolve, LLC
FarmaTrust Ltd.
We found that recent developments across the industry reflect accelerating consortium-network formation and platform expansion among leading vendors.
|
Date |
Event |
|
May 2026 |
Fujitsu Limited and IBM Japan formalized a strategic healthcare collaboration to develop a secure, sovereign cloud platform for medical use. The infrastructure integrates decentralized ledger security and data governance standards to streamline electronic health record (EHR) sharing across multi-institutional healthcare providers in Japan |
|
April 2026 |
IBM announced a major enterprise infrastructure collaboration with Arm to build secure, dual-architecture processing layers optimized for high-compliance workloads, supporting confidential computing models essential for distributed blockchain and healthcare data networks. |
|
August 2025 |
Patientory announced the integration and official launch of its AI-Enterprise Analytics Dashboard on the Oracle Healthcare Marketplace, empowering clinical networks and medical organizations to securely manage decentralized patient health records with enhanced data integrity. |
Capital inflows are concentrating around consortium claims-adjudication platforms and drug-traceability infrastructure, reflecting payer and pharmaceutical distributor demand for fraud-resistant, compliant systems. Our findings suggest that venture and strategic investment is favoring vendors with established TEFCA and Drug Supply Chain Security Act compliance credentials, given healthcare procurement cycles that reward regulatory readiness over generalist blockchain tooling.
Infrastructure investment is shifting toward consortium-node hosting and cloud-based confidential computing environments that support multi-stakeholder healthcare networks. We observed that diversified cloud vendors are expanding healthcare-specific compliance certifications to attract hospital and payer workloads, reinforcing infrastructure investment as a prerequisite for consortium-network participation across the forecast period.
Environmental, Social, and Governance considerations center on energy-efficient consensus mechanisms, equitable patient-data access, and transparent governance of consortium networks. Our analysis shows that permissioned and consortium architectures, which dominate healthcare deployments, carry substantially lower energy footprints than public proof-of-work networks, supporting favorable ESG positioning for vendors emphasizing governance transparency and patient-data equity.
Healthcare industry leaders gain a reconciled view of segment-level demand, regional adoption patterns, and competitive positioning to prioritize consortium-network participation decisions. Next Move Strategy Consulting's analysis indicates that this report's segmentation and forecast data support informed vendor-selection and interoperability-investment planning across provider and payer organizations.
Investors and financial analysts gain reconciled market-sizing, regional growth-rate, and competitive-landscape data to evaluate capital-allocation decisions across the blockchain in healthcare value chain. Our assessment indicates that the report's forecast methodology and company-profile data support due-diligence processes for private-equity and strategic-investment evaluations.
Technology vendors and product teams gain segment-level demand signals and regional regulatory context to prioritize product-roadmap and go-to-market investment decisions. We found that the report's application and end-user segmentation data support prioritization of consortium-network features and geographic expansion sequencing across the forecast period.
By Offering
Software
Platform Software
Blockchain Infrastructure
Smart Contract Platform
Identity Platform
Interoperability Platform
Node and Network Management
Application Software
Clinical Data Exchange
Drug Supply Chain
Claims and Billing
Clinical Research
Patient Identity
Provider Credentialing
Patient Engagement
Healthcare Payments
Medical Device Tracking
Other Healthcare Applications
Services
Consulting
Implementation
Integration
Managed Services
Support
Training
By Application
Clinical Data Exchange
Electronic Health Record Exchange
Medical Imaging Exchange
Laboratory Data Exchange
Health Information Exchange
Drug Supply Chain
Drug Serialization
Drug Traceability
Anti-Counterfeiting
Cold Chain Monitoring
Claims and Billing
Claims Processing
Prior Authorization
Fraud Detection
Payment Reconciliation
Clinical Research
Clinical Trial Management
Electronic Consent
Research Data Exchange
Real-World Evidence
Patient Identity
Identity Management
Consent Management
Provider Credentialing
Provider License Verification
Provider Certification Management
Credential Repository
Patient Engagement
Personal Health Records
Care Coordination
Wellness
Patient Portal
Healthcare Payments
Provider Payments
Member Payments
Smart Contract Settlement
Cross-Border Settlement
Medical Device Tracking
Device Identification
Device Lifecycle Tracking
Device Authentication
Other Healthcare Applications
Organ Donation Management
Genomic Data Management
Public Health Surveillance
By Deployment
Public Cloud
Private Cloud
Hybrid Cloud
On-Premises
By Blockchain Architecture
Public
Private
Consortium
Hybrid
By Revenue Model
Subscription
Perpetual License
Consumption-Based
Project-Based
Support Contract
By Organization Size
Large Enterprise
Medium Enterprise
Small Enterprise
By Sales Channel
Direct Sales
System Integrators
Technology Partners
Cloud Marketplace
By End User
Healthcare Providers
Hospitals
Clinics
Ambulatory Care Centers
Diagnostic Laboratories
Healthcare Payers
Commercial Payers
Government Payers
Third-Party Administrators
Life Sciences
Pharmaceutical Companies
Biotechnology Companies
Medical Device Companies
Contract Research Organizations
Government
Public Health Agencies
Regulatory Authorities
Pharmacies and Distributors
Retail Pharmacies
Hospital Pharmacies
Pharmaceutical Wholesalers
Research Organizations
Academic Institutions
Independent Research Organizations
Patients
Individual Consumers
Patient Advocacy Organizations
Other Healthcare Organizations
By Region
North America: U.S., Canada, Mexico.
Europe: UK, Germany, France, Italy, Spain, Sweden, Denmark, Finland, Netherlands, Rest of Europe.
Asia-Pacific: China, India, Japan, South Korea, Taiwan, Indonesia, Vietnam, Australia, Philippines, Malaysia, Rest of APAC.
Middle East & Africa: Saudi Arabia, UAE, Egypt, Israel, Turkey, Nigeria, South Africa, Rest of MEA.
Latin America: Brazil, Argentina, Chile, Colombia, Rest of LATAM.
The long-term outlook remains strongly positive, with the market forecast to expand from USD 5.05 billion in 2026 to USD 70.00 billion by 2035 at a 33.9% CAGR. Our analysis shows that sustained regulatory pressure for interoperability, combined with rising cyber-breach costs, will continue to anchor demand for tamper-evident, consortium-governed healthcare data infrastructure through the forecast horizon.
Vendors should prioritize consortium-network interoperability and regulatory-compliance depth over standalone point-solution features to secure long-term health-system contracts. Our assessment indicates that vendors investing early in TEFCA and CMS interoperability certification, alongside decentralized identity capability, will be best positioned to capture premium enterprise contracts within the blockchain in healthcare market.
The blockchain in healthcare industry presents an attractive investment case, supported by a USD 64.95 billion absolute dollar opportunity between 2026 and 2035 and above-average growth in Asia-Pacific and Medical Device Tracking categories. We found that investment attractiveness is highest for vendors combining regulatory-compliance credentials with scaled consortium-network participation, positioning them to serve both cost-sensitive and premium health-system segments simultaneously.
Stakeholders should monitor legacy-system integration costs, fragmented cross-jurisdiction regulatory standards, and competitive pressure from non-ledger interoperability platforms as key risks to the market. Our analysis shows that vendors unable to demonstrate measurable fraud-reduction or interoperability outcomes risk losing budget allocation to competitors offering simpler, non-blockchain data-exchange alternatives.
Key growth pathways include expanding consortium claims-adjudication networks, scaling drug-traceability infrastructure, and deepening decentralized identity penetration across provider credentialing. Next Move Strategy Consulting's analysis indicates that vendors pursuing these pathways while maintaining regulatory-compliance depth will be best positioned to capture the blockchain in healthcare market's projected growth through 2035.